BIIB

Biogen Idec Inc. News Headlines

$360.67
*  
6.97
1.97%
Get BIIB Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
3 Biotech Stocks to Buy in December
12/10/2014 9:18:02 AM - Motley Fool


Avalanche Biotechnologies (AAVL) Jumps: Stock Adds 6.1% in Session - Tale of the Tape
12/10/2014 9:11:00 AM - Zacks.com


ISIS Jumps on Positive Results for Venous Thrombosis Drug - Analyst Blog
12/9/2014 6:35:00 PM - Zacks.com


Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog
12/9/2014 6:20:00 PM - Zacks.com


Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog
12/9/2014 5:20:00 PM - Zacks.com


Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog
12/9/2014 5:10:00 PM - Zacks.com


Amgen Successfully Expands Xgeva Label in the U.S. - Analyst Blog
12/9/2014 5:00:00 PM - Zacks.com


Rexahn Pharmaceuticals, Inc. (RNN) Rises: Stock Up 8.6% - Tale of the Tape
12/9/2014 9:32:00 AM - Zacks.com


Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape
12/9/2014 9:21:00 AM - Zacks.com


bluebird bio (BLUE) in Focus: Stock Surges 9.4% - Tale of the Tape
12/9/2014 8:44:00 AM - Zacks.com


Amgen Unveils Positive Results from Blood Cancer Studies - Analyst Blog
12/8/2014 7:05:00 PM - Zacks.com


Pharmacyclics (PCYC) Launches U.S.-Based CLL Registry - Analyst Blog
12/8/2014 6:50:00 PM - Zacks.com


Agios (AGIO) Reports Encouraging Data on Leukemia Drug - Analyst Blog
12/8/2014 4:35:00 PM - Zacks.com


Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect - Analyst Blog
12/8/2014 3:20:00 PM - Zacks.com


AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog
12/8/2014 2:50:00 PM - Zacks.com


Cara Therapeutics (CARA) in Focus: Stock Rises 6.1% - Tale of the Tape
12/8/2014 9:46:00 AM - Zacks.com


Compugen (CGEN) Worth Watching: Stock Moves 8.8% Higher - Tale of the Tape
12/8/2014 9:25:00 AM - Zacks.com


Kindred Biosciences, Inc. (KIN) in Focus: Stock Soars 10.6% - Tale of the Tape
12/8/2014 9:18:00 AM - Zacks.com


Biogen's Alzheimer Surprise
12/8/2014 12:50:00 AM - Seeking Alpha


3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't
12/7/2014 12:39:02 PM - Motley Fool


Exciting News: A Game-Changing Alzheimer's Drug Could be on Its Way
12/6/2014 10:43:02 AM - Motley Fool


Walgreens (WAG) Up on 4.9% Y/Y Rise in November Sales - Analyst Blog
12/5/2014 4:45:00 PM - Zacks.com


Celldex's Glembatumumab Vedotin in Phase II for Melanoma - Analyst Blog
12/5/2014 3:10:00 PM - Zacks.com


What Biogen Idec's Alzheimer's Candidate Could Be Worth
12/5/2014 3:02:00 PM - Seeking Alpha


Incyte's Jakafi Gets FDA Approval for Polycythemia Vera - Analyst Blog
12/5/2014 1:00:00 PM - Zacks.com